To evaluate the prognostic value of extracellular volume (ECV) fraction derived from contrast-enhanced computed tomography (CECT) in predicting survival outcomes of resectable pancreatic ductal adenocarcinoma (PDAC).
To evaluate the prognostic value of extracellular volume (ECV) fraction derived from contrast-enhanced computed tomography (CECT) in predicting survival outcomes of resectable pancreatic ductal adenocarcinoma (PDAC).